Lansoprazole + Lansoprazole + placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Frequent Heartburn
Conditions
Frequent Heartburn
Trial Timeline
Jan 1, 2007 → Aug 1, 2007
NCT ID
NCT00701259About Lansoprazole + Lansoprazole + placebo
Lansoprazole + Lansoprazole + placebo is a phase 3 stage product being developed by Novartis for Frequent Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00701259. Target conditions include Frequent Heartburn.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00701259 | Phase 3 | Completed |
Competing Products
1 competing product in Frequent Heartburn
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Rabeprazole sodium | Eisai | Pre-clinical | 23 |